Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.

Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect (2003) 1.87

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A (2000) 1.57

Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest (2002) 1.43

Significance of the blood beryllium lymphocyte proliferation test. Environ Health Perspect (1996) 1.20

Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest (2005) 1.17

Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med (1997) 1.16

The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect (1996) 1.12

Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis (1989) 1.07

Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease. J Immunol (2008) 0.97

Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol (1996) 0.97

Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96

Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. J Exp Med (2013) 0.95

Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med (2010) 0.95

Novel in vitro method for identification of individuals at risk for beryllium hypersensitivity. Clin Diagn Lab Immunol (1994) 0.94

Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition. J Immunol (2011) 0.92

CD27 expression on CD4+ T cells differentiates effector from regulatory T cell subsets in the lung. J Immunol (2009) 0.91

Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol (2011) 0.87

Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med (2009) 0.86

Gene-environment interactions in the development of complex disease phenotypes. Int J Environ Res Public Health (2008) 0.86

T cell recognition of beryllium. Curr Opin Immunol (2013) 0.86

Identification of multiple public TCR repertoires in chronic beryllium disease. J Immunol (2014) 0.84

Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation. J Immunol (2013) 0.83

4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease. J Immunol (2008) 0.82

Linking genetic susceptibility and T cell activation in beryllium-induced disease. Proc Am Thorac Soc (2010) 0.81

Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol (2006) 0.81

Chronic beryllium disease: uncommon disease, less common diagnosis. Environ Health Perspect (1998) 0.79

Lung function, biological monitoring, and biological effect monitoring of gemstone cutters exposed to beryls. Occup Environ Med (2000) 0.79

Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility. J Occup Environ Med (2010) 0.78

Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation. J Immunol (2016) 0.77

Introduction to the conference on beryllium-related diseases. Environ Health Perspect (1996) 0.77

Advances in identifying beryllium sensitization and disease. Int J Environ Res Public Health (2010) 0.75

On the differential diagnosis of chronic beryllium disease and sarcoidosis. Am Rev Respir Dis (1990) 0.75

Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol (2009) 0.75

Current treatment of chronic beryllium disease. J Occup Environ Hyg (2009) 0.75

Clinical application of beryllium lymphocyte proliferation testing. Clin Diagn Lab Immunol (2003) 0.75

SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med (2011) 0.75

CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge. J Immunotoxicol (2015) 0.75

Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung (2011) 0.75

Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 11.24

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95

Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol (1992) 3.79

Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2001) 3.69

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A (1994) 3.24

An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis (1989) 3.12

Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol (1984) 3.02

An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am (2005) 2.92

Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med (1992) 2.91

Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods (1994) 2.85

Studies on cytochrome oxidase. Interactions of the cytochrome oxidase protein with phospholipids and cytochrome c. J Biol Chem (1975) 2.80

Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br (2008) 2.79

Revision of metal-on-metal resurfacing arthroplasty of the hip: the influence of malpositioning of the components. J Bone Joint Surg Br (2008) 2.28

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J (2009) 2.14

Association of blood pressure and polychlorinated biphenyl levels. JAMA (1981) 2.07

Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis (1990) 2.02

Listeria cell wall fraction: a B cell mitogen. J Immunol (1975) 1.94

Gentamicin kills intracellular Listeria monocytogenes. Infect Immun (1994) 1.94

Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol (1991) 1.85

Metal ion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing. J Bone Joint Surg Am (2008) 1.85

Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.85

Studies on cytochrome oxidase. 8. Preparation and some properties of cardiac cytochrome oxidase. J Biol Chem (1972) 1.84

Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med (1990) 1.83

Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J Immunol Methods (1991) 1.83

Building-related respiratory symptoms can be predicted with semi-quantitative indices of exposure to dampness and mold. Indoor Air (2004) 1.79

Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur Respir J (2004) 1.75

Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res (1998) 1.75

Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol (1979) 1.69

Listeria monocytogenes infects human endothelial cells by two distinct mechanisms. Infect Immun (1995) 1.68

Cross-sectional study of a community with exceptional exposure to DDT. JAMA (1981) 1.68

Tissue reaction to metal on metal total hip prostheses. Clin Orthop Relat Res (1996) 1.66

Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest (1991) 1.66

Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol (1991) 1.65

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis (1986) 1.65

Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes. J Immunol (1985) 1.64

Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J (2002) 1.63

The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal? J Consult Clin Psychol (1995) 1.59

Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun (1991) 1.55

Screening blood test identifies subclinical beryllium disease. J Occup Med (1989) 1.55

Beryllium disease: assessment with CT. Radiology (1994) 1.54

Deuterium nuclear magnetic resonance investigation of the effects of proteins and polypeptides on hydrocarbon chain order in model membrane systems. Proc Natl Acad Sci U S A (1978) 1.53

Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med (1996) 1.53

Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J (2011) 1.52

Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis (1987) 1.52

Massive femoral osteolysis and early disintegration of a polyethylene-bearing surface of a total knee replacement. A case report. J Bone Joint Surg Am (1992) 1.48

Induction of Resistance by Listeria monocytogenes Cell Wall Fraction. Infect Immun (1974) 1.48

Challenges in pulmonary fibrosis: 8--The need for an international registry for idiopathic pulmonary fibrosis. Thorax (2008) 1.48

Interactions of bilirubin with bovine serum albumin in aqueous solution. J Biol Chem (1970) 1.44

The complete amino acid sequence of bovine heart cytochrome C1. Biochem Biophys Res Commun (1980) 1.43

Listericidal and nonlistericidal mouse macrophages differ in complement receptor type 3-mediated phagocytosis of L. monocytogenes and in preventing escape of the bacteria into the cytoplasm. J Leukoc Biol (1992) 1.42

Contractor safety practices and injury rates in construction of the Denver International Airport. Am J Ind Med (1999) 1.41

Analysis of construction injury burden by type of work. Am J Ind Med (2000) 1.40

Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health (2001) 1.40

Requirement for bone marrow-derived cells in resistance to Listeria. J Immunol (1974) 1.40

Endemic work-related febrile respiratory illness among construction workers. Am J Ind Med (1995) 1.39

Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med (1997) 1.38

Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions. J Immunol (1977) 1.36

GLUCOSE CATABOLISM IN THE ERGOT FUNGUS, CLAVICEPS PURPUREA. J Bacteriol (1960) 1.36

Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method. Am Rev Respir Dis (1988) 1.36

Notching of the femoral neck during resurfacing arthroplasty of the hip: a vascular study. J Bone Joint Surg Br (2006) 1.36

Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity. Immunology (1985) 1.35

Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis (2005) 1.35

Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med (1994) 1.34

Low-temperature kinetics of the reaction of oxygen and solubilized cytochrome oxidase. Biochem J (1978) 1.32

Removal of immunoglobulin-bearing lymphocytes by anti-immunoglobulin-coated columns. Cell Immunol (1972) 1.32

How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med (1995) 1.31

Immunocompetent cells in resistance to bacterial infections. Bacteriol Rev (1976) 1.31

Killing of Listeria monocytogenes by human neutrophils and monocytes, but not by monocyte-derived macrophages. J Reticuloendothel Soc (1983) 1.28

Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med (1991) 1.27

Kinetics of electron transfer between cardiac cytochrome c 1 and c. J Biol Chem (1973) 1.26

Fungal and endotoxin measurements in dust associated with respiratory symptoms in a water-damaged office building. Indoor Air (2006) 1.23

Serial PBB levels, PCB levels, and clinical chemistries in Michigan's PBB cohort. Arch Environ Health (1982) 1.23

Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med (1997) 1.22

Studies on populations exposed to polychlorinated biphenyls. Environ Health Perspect (1985) 1.22

Heme-heme interaction in cytochrome c oxidase: the cooperativity of the hemes of cytochrome c oxidase as evidenced in the reaction with CO. Arch Biochem Biophys (1974) 1.21

Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma. Am Rev Respir Dis (1991) 1.21

Construction injury rates may exceed national estimates: evidence from the construction of Denver International Airport. Am J Ind Med (1998) 1.20

Mixing and matching causing taper wear: corrosion associated with pseudotumour formation. J Bone Joint Surg Br (2012) 1.19

Preparation and properties of cardiac cytochrome c 1 . J Biol Chem (1972) 1.17

Studies on cytochrome oxidase. II. A reaction of cyanide with cytochrome oxidase in soluble and particulate forms. J Biol Chem (1966) 1.16

Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 1.16

Listeria cell wall fraction: a B cell adjuvant. J Immunol (1976) 1.16

Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest (1990) 1.15

Reduction of the potential for thermal damage during hip resurfacing. J Bone Joint Surg Br (2007) 1.15

Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis (1989) 1.15

Complement receptor type 3 (CD11b/CD18) involvement is essential for killing of Listeria monocytogenes by mouse macrophages. J Immunol (1993) 1.14

Temperature dependence of the electron spin-lattice relaxation rate from pulsed EPR of CUA and heme a in cytochrome c oxidase. Biophys J (1984) 1.14

Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J (2006) 1.14

Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res (1996) 1.14

Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore) (2000) 1.13

Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol (1995) 1.13

Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol (1992) 1.12

Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Indoor Air (2009) 1.12

Thioglycolate medium decreases resistance to bacterial infection in mice. Infect Immun (1980) 1.11

The pleuropulmonary manifestations of the postcardiac injury syndrome. Chest (1983) 1.11

Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1995) 1.10

Thermodynamic and EPR characteristics of a HiPIP-type iron-sulfur center in the succinate dehydrogenase of the respiratory chain. J Biol Chem (1976) 1.10

Nuclear magnetic resonance investigation of the cytochrome oxidase--phospholipid interaction: a new model for boundary lipid. Biochemistry (1979) 1.09